No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
APLS240816P25000
- 0.25
- -0.35-58.33%
15min DelayClose Jul 22 15:21 ET
0.27High0.25Low
0.27Open0.60Pre Close5 Volume5 Open Interest25.00Strike Price133.00Turnover101.85%IV33.23%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.25Extrinsic Value100Contract SizeAmericanOptions Type-0.0535Delta0.0109Gamma148.28Leverage Ratio-0.0208Theta-0.0014Rho-7.93Eff Leverage0.0106Vega
Intraday
- 5D
- Daily
News
Citi Maintains Apellis Pharmaceuticals(APLS.US) With Buy Rating, Maintains Target Price $60
Citi analyst Yigal Nochomovitz maintains $Apellis Pharmaceuticals(APLS.US)$ with a buy rating, and maintains the target price at $60.According to TipRanks data, the analyst has a success rate of 45.4%
Piper Sandler Maintains Apellis Pharmaceuticals(APLS.US) With Hold Rating, Maintains Target Price $46
Piper Sandler analyst Biren Amin maintains $Apellis Pharmaceuticals(APLS.US)$ with a hold rating, and maintains the target price at $46.According to TipRanks data, the analyst has a success rate of 42
Piper Sandler Reaffirms Their Hold Rating on Apellis Pharmaceuticals (APLS)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Apellis Pharmaceuticals (APLS) and EDAP TMS (EDAP)
Buy Rating Affirmed on Apellis Pharmaceuticals Amid Promising Pegcetacoplan Trials and Expert Optimism
Jefferies Maintains Apellis Pharmaceuticals(APLS.US) With Buy Rating, Maintains Target Price $80
Jefferies analyst Akash Tewari maintains $Apellis Pharmaceuticals(APLS.US)$ with a buy rating, and maintains the target price at $80.According to TipRanks data, the analyst has a success rate of 59.5%
Comments
$Apellis Pharmaceuticals(APLS.US$ they are going to have better earnings than last quarter
2
$Apellis Pharmaceuticals(APLS.US$ I'm shocked this had not done anything. it hit bottom at 19.83 after the big scare panic sell off from mid 80s , bounce back up past 70. stupid corporate keeps selling off scaring investors. this is actually bargain price for this company
2
Read more
EZ_moneyOP : did you see those PTs
EZ_moneyOP : back to +40